Anlon Healthcare IPO: Subscribed 50% on Day 1, Retail Portion Surges 5x

The buzz around Anlon Healthcare IPO kicked off strongly as the company’s maiden public issue hit the markets. Within the very first day, the IPO has already captured half of its total target—clearly showing strong retail enthusiasm.

Let’s break down how the subscription played out and what the early demand tells us.

Market Performance

The ₹121 crore Anlon Healthcare IPO opened for public bidding on August 26. On Day 1, it achieved 50% subscription, a solid start for the Rajkot-based company.

• Shares offered: 1.33 crore
  
  
• Bids received (till 12:10 pm on NSE): Over 67 lakh
  
  
• Overall subscription: 50% by Day 1
  
  

The pace of subscriptions, especially from retail investors, became the key highlight.

Subscription Breakdown

Investor appetite wasn’t equal across categories. Here’s how different investor groups participated on Day 1:

• Retail Investors: Oversubscribed 5 times their allocated portion
  
  
• Non-Institutional Investors (NII): Subscribed 23% of their quota
  
  
• Qualified Institutional Buyers (QIBs): Yet to make significant bids
  
  

Clearly, the retail side has taken the lead, while institutional investors are still waiting on the sidelines.

Anlon Healthcare IPO GMP

Even before hitting the stock exchanges, Anlon Healthcare shares are drawing attention in the unlisted space.

• Grey Market Premium (GMP): Trading 5–7% above IPO price
  
  
• IPO Price: ₹96 per share
  
  
• GMP Range: ₹5.5 – ₹7 premium in the grey market
  
  

This shows early investor sentiment leaning positive, with the market expecting listing gains above the issue price.

Company Snapshot

Anlon Healthcare, headquartered in Rajkot, is stepping into the mainboard space with its first-ever public issue. The IPO worth ₹121 crore is designed to bring the company closer to the larger investor community, while also signaling strong growth ambitions.

Quick Summary

• IPO Size: ₹121 crore
  
  
• Total Shares Offered: 1.33 crore
  
  
• Day 1 Subscription: 50%
  
  
• Retail Subscription: 5x oversubscribed
  
  
• NII Subscription: 23%
  
  
• QIBs: Yet to participate
  
  
• GMP: 5–7% over IPO price of ₹96
  
  

The early response shows how retail investors are driving momentum in the IPO, with the grey market also backing up the optimism.